cerict - OPTObacteria

OPTObacteria

Project

OPTObacteria

Title	Multianalyte automatic system for the detection of drug resistant bacteria.	Acronym	OPTObacteria
Project ID	286998	Call	FP7-SME-2011
Programme	FP7	Rdg	REA
Activity

Links
Project site http://www.optobacteria.eu/default.aspx Project details http://cordis.europa.eu/project/rcn/105638_en.html Final Report http://www.cordis.europa.eu/result/rcn/165733_en.html

Abstract

Abstract
Infectious disease are responsible of high human health burden and cost. Time to diagnosis release and quality of the microrganism detection represent an area of interest for optical fiber based device application. OPTObacteria propose an highly expert consortium in which 4 SME and 4 research peformers from 3 European countries would synergize their efforts to provide a unique Automatic Laboratory Detector (ALD) to deliver a drug resistance report in a 4 or 4-8 hours timeframe. The time is depending on the experiment required, it avoid bacterial grwoth time, typical of the antibiogram typical report and provide an detection up to low ng concentration or even low. With respect to other optical-based device (like SPR, surface plamon resosnance) many limitations are overcome.

Partner

Partner
TYDOCK PHARMA S.r.l(990039813)-COORDINATOR MOLECULAR DISCOVERY LTD(997468655)-BENEFICIARY OPTOSMART SRL(991761466)-BENEFICIARY UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA(999840887)-BENEFICIARY CONSIGLIO NAZIONALE DELLE RICERCHE(999979500)-BENEFICIARY Centro Regionale Information Communication Technology scrl(986394262)-BENEFICIARY AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS(999991722)-BENEFICIARY PROYECCION EUROPLAN XXI S.L.(953806142)-BENEFICIARY FUNDACION PUBLICA ANDALUZA PARA LAGESTION DE LA INVESTIGACION EN SALUD DE SEVILLA(994159888)-BENEFICIARY

Go Top